It is a no brainer that if you take out additional tumors the people have a better chance to survive longer.
This is true to a point. The most important factor indetermining resectability and prognosis is the number of metastatic nodules. Worse survival rates have actually been shown when 4 or more metastatic nodules are resected.
I would certainly want this tool if I was having surgery.
I will look to buy this stock again, but I'am in no hurry.
Market Data 
Markets 
AI
